| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.735 | 42.344 | 19.757 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 41.735 | 42.344 | 19.757 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 41.420 | 41.424 | 22.037 | 4.679 | 3.269 | 1.097 | 3.263 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 315 | 921 | -2.280 | -4.679 | -3.269 | -1.097 | -3.263 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -937 | 73 | -6.082 | -4.679 | -3.269 | -1.097 | -3.263 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Posermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.169 | 2.443 | 1.687 | 1.641 | 1.610 | 1.579 | 0 | 0 | 0 | 0 |
| Current Assets | 3.084 | 12.435 | 3.342 | 1.778 | 1.696 | 1.654 | 197 | 198 | 197 | 196 |
| Inventories | 2.852 | 2.243 | 1.751 | 1.719 | 1.686 | 1.654 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 232 | 10.192 | 1.591 | 59 | 10 | 0 | 196 | 197 | 197 | 195 |
| Shareholders Funds | -16.642 | -16.399 | -22.203 | -26.474 | -29.231 | -29.774 | -32.377 | -32.477 | -32.379 | -32.198 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 22.895 | 31.278 | 27.233 | 29.894 | 32.537 | 33.007 | 32.574 | 32.675 | 32.576 | 32.394 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Posermed Srl